Here are three notes on the report’s findings:
1. The majority of participating oncologists predict that, within the next three or more years, AI will enhance the quality of care, clinical outcomes and operational efficiencies. Nearly half also expect AI to lower the cost of care.
2. More than a third of oncologists surveyed said the most valuable benefit AI could bring to their practice would be automating administrative tasks so they can spend more time with patients, while 27 percent said AI will have the greatest impact by identifying the best treatment paths and therapies from the start of a patient’s care plan.
3. According to Oncology Insights, other ways providers believe AI can improve cancer care include predicting patients’ risk of complications from treatment and enhancing the accuracy of diagnostics.
More articles about AI:
IBM Watson Health’s clinical support in cancer care proven by multiple studies
Startup using AI, AR to detect Alzheimer’s 10 years before onset raises $6.3M
Precision medicine startup Tempus raises $200M to reach $3.1B valuation
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
